kentucky semaglutide nausea lawsuit louisiana legal team digestive blockage law office in gastric intestinal obstruction firm glp semaglutide nausea lawsuit in kentucky

Qualifying Injuries Include: Gastrointestinal Injuries: Gastroparesis (stomach paralysis) confirmed by gastric emptying scan Persistent vomiting requiring hospitalization or IV fluids Intestinal blockage or ileus requiring emergency treatment Chronic digestive problems persisting after stopping the drug Severe malnutrition or dehydration from inability to eat Need for feeding tube or IV nutrition (TPN) Vision Injuries: Sudden vision loss (NAION) diagnosed by ophthalmologist Permanent or long-term vision impairment Eye stroke while taking GLP-1 medication Other Serious Complications: Emergency surgery related to GI complications Multiple hospitalizations for medication side effects Gallbladder disease requiring surgery Pancreatitis confirmed by testing Why Choose Our Firm

Jellinger K, 1988

Understanding Semaglutide: An Overview Semaglutide is a GLP-1 receptor agonist that has received FDA approval for weight management in individuals with high body mass index (BMI) or weight-related health conditions

Current as of 6/18/26 Are there any clinical criteria for approval (e.g., BMI level, sustained weight min/max, step therapy such as a weight loss management program)

Kiani AK, Donato K, Dhuli K, Stuppia L, Bertelli M